Table 5.
Model | Oral Contraceptives | Estrogen Alone | Progestin ± Estrogen |
---|---|---|---|
— OR (95% CI, P-value) — | |||
Age-adjusted only | 2.64 (1.52–4.60, <0.001) | 1.29 (0.89–1.87, 0.18) | 2.02 (1.36–2.99, <0.001) |
Body mass index (kg/m2) | 2.59 (1.47–4.57, 0.001) | 1.36 (0.93–1.99, 0.11) | 2.30 (1.53–3.45, <0.001) |
Hospitalization, with or without surgery | 3.22 (1.70–6.13, <0.001) | 1.33 (0.85–2.09, 0.21) | 2.08 (1.33–3.27, 0.002) |
Nursing home confinement | 2.64 (1.52–4.60, <0.001) | 1.31 (0.90–1.91, 0.16) | 2.07 (1.39–3.07, <0.001) |
Trauma/fracture | 2.56 (1.46–4.47, 0.001) | 1.34 (0.91–1.96, 0.14) | 2.16 (1.43–3.26, <0.001) |
Active cancer | 2.97 (1.66–5.32, <0.001) | 1.52 (1.01–2.28, 0.04) | 1.72 (1.12–2.65, 0.013) |
Neurologic Disease w/Leg paresis | 3.01 (1.69–5.35, <0.001) | 1.27 (0.87–1.85, 0.21) | 1.98 (1.33–2.95, <0.001) |
Varicose veins | 2.63 (1.51–4.58, <0.001) | 1.27 (0.88–1.85, 0.20) | 2.02 (1.36–2.99, <0.001) |
Pregnancy or postpartum | 3.45 (1.87–6.34, <0.001) | 1.27 (0.87–1.84, 0.21) | 2.00 (1.35–2.97, <0.001) |